Скачать или смотреть The critical role of data in addressing antimicrobial resistance for better cancer treatment & care

People with cancer are more susceptible to infections due to the lowering of their immune defences. Infections are the second leading cause of death among cancer patients, after the cancer itself. The emergence of drug-resistant pathogens are negatively affecting cancer care and if countermeasures are not taken now, all the progress made in cancer care will be undermined.

Data on the impact of antimicrobial resistance (AMR) on cancer care is scarce. To effectively address this issue, it is critical to prioritise data collection and surveillance. They are essential in informing evidence-based policy and interventions.

This UICC Virtual Dialogue focused on the importance of data and discuss recent publications on the topic.

Speakers
Antonella Cardone, Cancer Patients Europe
Diane Flayhart, BD
Najy Alsayed, Menarini Group
Yehoda Martei, University of Pennsylvania
Moderator: Shalini Jayasekar Zurn, UICC